Bank of New York Mellon’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.18M Buy
140,755
+11,276
+9% +$174K ﹤0.01% 2698
2025
Q1
$1.93M Buy
129,479
+24,587
+23% +$366K ﹤0.01% 2695
2024
Q4
$1.39M Buy
104,892
+15,388
+17% +$204K ﹤0.01% 2928
2024
Q3
$1.27M Sell
89,504
-30
-0% -$427 ﹤0.01% 2996
2024
Q2
$1.16M Sell
89,534
-21,735
-20% -$281K ﹤0.01% 3107
2024
Q1
$1.55M Sell
111,269
-9,027
-8% -$125K ﹤0.01% 2910
2023
Q4
$1.72M Sell
120,296
-16,797
-12% -$240K ﹤0.01% 2903
2023
Q3
$2.12M Sell
137,093
-3,841
-3% -$59.4K ﹤0.01% 2772
2023
Q2
$2.21M Sell
140,934
-9,186
-6% -$144K ﹤0.01% 2775
2023
Q1
$2.47M Buy
150,120
+9,298
+7% +$153K ﹤0.01% 2680
2022
Q4
$2.2M Buy
140,822
+41,104
+41% +$641K ﹤0.01% 2811
2022
Q3
$1.29M Buy
99,718
+28,273
+40% +$367K ﹤0.01% 3084
2022
Q2
$1M Buy
71,445
+7,644
+12% +$107K ﹤0.01% 3208
2022
Q1
$914K Buy
63,801
+13,205
+26% +$189K ﹤0.01% 3369
2021
Q4
$689K Sell
50,596
-10,570
-17% -$144K ﹤0.01% 3597
2021
Q3
$1M Sell
61,166
-5,082
-8% -$83.3K ﹤0.01% 3389
2021
Q2
$1.12M Buy
66,248
+1,057
+2% +$17.8K ﹤0.01% 3336
2021
Q1
$1.19M Sell
65,191
-16,982
-21% -$310K ﹤0.01% 3238
2020
Q4
$1.5M Sell
82,173
-3,667
-4% -$66.8K ﹤0.01% 3013
2020
Q3
$1.53M Sell
85,840
-24,044
-22% -$429K ﹤0.01% 2836
2020
Q2
$1.97M Sell
109,884
-21,311
-16% -$382K ﹤0.01% 2690
2020
Q1
$1.99M Buy
131,195
+21,494
+20% +$326K ﹤0.01% 2545
2019
Q4
$2.16M Sell
109,701
-14,692
-12% -$290K ﹤0.01% 2782
2019
Q3
$2.14M Sell
124,393
-43,795
-26% -$753K ﹤0.01% 2722
2019
Q2
$2.98M Sell
168,188
-102,636
-38% -$1.82M ﹤0.01% 2592
2019
Q1
$5.52M Buy
270,824
+245,980
+990% +$5.01M ﹤0.01% 2289
2018
Q4
$418K Buy
+24,844
New +$418K ﹤0.01% 3572